Capital raised by Infinity Bio
1 Form D filing · first filed Feb 2025 · Baltimore, MD
Chief Executive Officer
Signatory on Infinity Bio's Form D filings · $2.0M raised across 1
Joy M. Nassif is on file as Chief Executive Officer at Infinity Bio in Baltimore, MD. Infinity Bio has 1 Form D filing on record, $2.0M raised in total. Joy M. Nassif appears as a signatory on the company's filings.
MIPSA is Infinity Bio's proprietary technology designed for the intricate mapping of antibody reactivity against large libraries of antigens. This innovative platform allows for comprehensive profiling of antibodies, facilitating a deeper understanding of immune responses.